Hypophosphatemia and multiple fractures in patient with human immunodeficiency virus infection treated with tenofovir [1];Hipofosfatemia y múltiples fracturas en un paciente con infección por el virus de la inmunodeficiencia humana y en tratamiento con tenofovir

Medicina Clinica

Volumn 129, Issue 5, 2007, Pages 197-

  Roselló, Lluís ^a   Gort, Anna ^a   Planella, Ramón ^a   Cabau, Jacint ^a  

^a HOSPITAL DE SANTA MARIA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

DIDANOSINE; LOPINAVIR; RITONAVIR; TENOFOVIR;

ADULT; CASE REPORT; CLINICAL EVALUATION; DRUG EFFECT; DRUG INDUCED DISEASE; FRACTURE; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOPHOSPHATEMIA; LABORATORY TEST; LETTER; MALE; MYOPATHY; OSTEOMALACIA;

EID: 34548556129     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1157/13107795     Document Type: Letter

References (8)

1. Earle KE, Seneviratne T, Shaker J, Shoback D. Fanconi's syndrome in HIV+ adults: report of three cases and literature review. J Bone Miner Res. 2004;19:714-21.
2. Parsonage MJ, Wilkins EG, Snowden N, Issa BG, Savage NW. The development of hypophosphataemia osteomalacia with myopathy in two patients with HIV+ infection receiving tenofovir therapy. HIV Med. 2006;7:484-5.
3. Antoniou T, Park-Wyllie LY, Tseng AL. Tenofovir: a nucleotide analog for the management of human immunodeficiency virus infection. Pharmacotherapy. 2003;23:29-43.
4. Van Rompay KK, Brignolo LL, Meyer Dj, Tarara R, Spinner A, Hamilton M. et al. Biological effects of short-term or prolloged administration of 9.(2-(phosphonometoxy)propyl) adenina (tenofovir) to newborn and infant Rhesus Macaques. Antimicrob Agents Chemother. 2004;48:1469-87.
5. Madeddu G, Quirino T, Carradori S, Ricci E, Grosso C, Penco G, et al. Renal toxicity in HIV-infected patients receiving HAART including tenofovir. Infez Med. 2006;14:125-34.
6. Izzedine H, Launay-Vacher V, Isnard-Bagnis C, Deray G. Drug induced Fanconi's syndrome. Am J Kindney Dis. 2003;41:292-309.
7. Izzedine H, Hulot JS, Villard E, Goyenvalle C, Dominguez S, Ghosn J, et al. Association between ABCC2 gene haplotypes and tenofovir-induced proximal tubulopathy. J Infect Dis. 2006;194:1481-91.
8. Rollot F, Nazal EM, Chauvelot-Moachon L, Kelaidi C, Daniel N, Saba M, et al. Tenofovir-related Fanconi syndrome with nephrogenic diabetes insipidus in a patient with acquired immunodeficiency syndrome, the role of lopinavir-ritonavir-didanosine. Clin Infect Dis. 2003;37:174-6.